Amyl Therapeutics uses a unique mechanism to target multiple misfolded proteins implicated in peripheral and neurodegenerative diseases. Their therapies aim to prevent further accumulation of aggregates and clear existing aggregates from organs and the brain. Their technology offers a curative solution for amyloid-mediated diseases, including rare and severe peripheral protein misfolding diseases and neurodegenerative diseases like Alzheimer's and Parkinson's.